MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 260 filers reported holding MYRIAD GENETICS INC in Q2 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $217 | -100.0% | 14,974 | -91.2% | 0.00% | -100.0% |
Q3 2022 | $3,239,000 | +91.3% | 169,774 | +82.2% | 0.01% | +150.0% |
Q2 2022 | $1,693,000 | -29.6% | 93,200 | -2.4% | 0.00% | -33.3% |
Q1 2022 | $2,406,000 | +129.6% | 95,474 | +151.4% | 0.00% | +200.0% |
Q4 2021 | $1,048,000 | -84.7% | 37,974 | -82.1% | 0.00% | -88.9% |
Q3 2021 | $6,832,000 | +211.7% | 211,574 | +195.2% | 0.01% | +200.0% |
Q2 2021 | $2,192,000 | +123.9% | 71,674 | +44.8% | 0.00% | +200.0% |
Q4 2020 | $979,000 | -30.5% | 49,491 | -54.2% | 0.00% | 0.0% |
Q3 2020 | $1,408,000 | +138.6% | 107,974 | +107.6% | 0.00% | 0.0% |
Q2 2020 | $590,000 | -77.4% | 52,000 | -45.8% | 0.00% | -50.0% |
Q4 2019 | $2,611,000 | -66.2% | 95,900 | -62.0% | 0.00% | -50.0% |
Q2 2018 | $7,736,000 | +21.6% | 252,074 | +17.1% | 0.00% | -42.9% |
Q1 2018 | $6,361,000 | -14.8% | 215,274 | -0.9% | 0.01% | -12.5% |
Q4 2017 | $7,462,000 | +28.8% | 217,279 | +35.7% | 0.01% | +14.3% |
Q3 2017 | $5,795,000 | -43.6% | 160,174 | -70.0% | 0.01% | -50.0% |
Q1 2017 | $10,266,000 | -77.1% | 534,700 | -80.1% | 0.01% | -80.3% |
Q4 2016 | $44,779,000 | -25.8% | 2,686,174 | -8.4% | 0.07% | -33.6% |
Q3 2016 | $60,334,000 | +48.0% | 2,931,674 | +120.0% | 0.11% | +37.2% |
Q2 2016 | $40,768,000 | +5.3% | 1,332,300 | +28.7% | 0.08% | +5.4% |
Q1 2016 | $38,733,000 | -5.5% | 1,034,800 | +9.0% | 0.07% | -16.9% |
Q4 2015 | $40,985,000 | +27.7% | 949,600 | +10.9% | 0.09% | +15.6% |
Q3 2015 | $32,105,000 | +47.6% | 856,600 | +33.9% | 0.08% | +54.0% |
Q2 2015 | $21,747,000 | +124.5% | 639,800 | +133.8% | 0.05% | +138.1% |
Q1 2015 | $9,689,000 | +202.6% | 273,700 | +191.2% | 0.02% | +162.5% |
Q4 2014 | $3,202,000 | +37.3% | 94,000 | +55.4% | 0.01% | +33.3% |
Q3 2014 | $2,332,000 | +21.8% | 60,474 | +22.9% | 0.01% | +50.0% |
Q2 2014 | $1,915,000 | -10.8% | 49,200 | -21.7% | 0.00% | -20.0% |
Q1 2014 | $2,147,000 | -71.8% | 62,800 | -82.7% | 0.01% | -72.2% |
Q4 2013 | $7,609,000 | -87.2% | 362,700 | -85.7% | 0.02% | -87.5% |
Q3 2013 | $59,550,000 | -2.8% | 2,534,031 | +11.2% | 0.14% | -10.6% |
Q2 2013 | $61,247,000 | – | 2,279,374 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |